This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Tag: Genomics
Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done
An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...
Rivian, Illumina, Toast, and More Stock Market Movers Friday
Text size Rivian, the maker of electric trucks, maintained its production estimates for the full year. Courtesy Rivian Stock futures rose Friday amid more signs that inflation in the U.S. has been coo...
Genomics company explores NFTs in hopes of advancing precision medicine
It’s predicted that nonfungible tokens (NFTs) will have a vast impact on society. Given this, it shouldn’t come as a surprise that the trillion-dollar healthcare sector has begun to explore NFTs token...
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetic...
James Anderson of Baillie Gifford on Illumina, Moderna, and Other Companies That Matter
James Anderson, a partner at Scottish money manager Baillie Gifford, has personified growth-stock investing during his 39 years with the firm. He was an early backer of Amazon.com, Tesla, and other “e...